Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis.
Zhang Q, McDermott GC, Juge PA, Chang SH, Vanni KM, Qian G, Bade KJ, Mueller KT, Kowalski EN, Saavedra AA, Sparks JA. Zhang Q, et al. Among authors: kowalski en. Semin Arthritis Rheum. 2024 Oct 11;69:152561. doi: 10.1016/j.semarthrit.2024.152561. Online ahead of print. Semin Arthritis Rheum. 2024. PMID: 39413452 Review.
Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer.
McCarter KR, Arabelovic S, Wang X, Wolfgang T, Yoshida K, Qian G, Kowalski EN, Vanni KMM, LeBoeuf NR, Buchbinder EI, Gedmintas L, MacFarlane LA, Rao DA, Shadick NA, Gravallese EM, Sparks JA. McCarter KR, et al. Among authors: kowalski en. Semin Arthritis Rheum. 2024 Feb;64:152335. doi: 10.1016/j.semarthrit.2023.152335. Epub 2023 Dec 8. Semin Arthritis Rheum. 2024. PMID: 38100899
Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease.
Venkat RK, Hayashi K, Juge PA, McDermott G, Paudel M, Wang X, Vanni KMM, Kowalski EN, Qian G, Bade KJ, Saavedra AA, Mueller KT, Chang SH, Dellaripa PF, Weinblatt ME, Shadick NA, Doyle TJ, Dieude P, Sparks JA. Venkat RK, et al. Among authors: kowalski en. Clin Rheumatol. 2024 Aug;43(8):2453-2466. doi: 10.1007/s10067-024-07028-w. Epub 2024 Jun 19. Clin Rheumatol. 2024. PMID: 38898318
Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis-Associated Interstitial Lung Disease Subtypes.
McDermott GC, Hayashi K, Juge PA, Gill R, Byrne S, Gagne S, Wang X, Paudel ML, Moll M, Cho MH, Vanni K, Kowalski E, Qian G, Bade K, Saavedra A, Kawano Y, DiIorio M, Wolfgang T, Kim EY, Dellaripa PF, Weinblatt ME, Shadick N, Doyle TJ, Sparks JA. McDermott GC, et al. Arthritis Care Res (Hoboken). 2024 Sep 11. doi: 10.1002/acr.25432. Online ahead of print. Arthritis Care Res (Hoboken). 2024. PMID: 39257341
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study.
Di Iorio M, Cook CE, Vanni KMM, Patel NJ, D'Silva KM, Fu X, Wang J, Prisco LC, Kowalski E, Zaccardelli A, Martin LW, Qian G, Hsu TY, Wallace ZS, Sparks JA. Di Iorio M, et al. Semin Arthritis Rheum. 2022 Aug;55:152025. doi: 10.1016/j.semarthrit.2022.152025. Epub 2022 May 18. Semin Arthritis Rheum. 2022. PMID: 35617780 Free PMC article.
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study.
Figueroa-Parra G, Gilbert EL, Valenzuela-Almada MO, Vallejo S, Neville MR, Patel NJ, Cook C, Fu X, Hagi R, McDermott GC, Dilorio MA, Masto L, Vanni KMM, Kowalski E, Qian G, Zhang Y, Wallace ZS, Duarte-García A, Sparks JA. Figueroa-Parra G, et al. Lancet Rheumatol. 2022 Nov;4(11):e765-e774. doi: 10.1016/S2665-9913(22)00227-2. Epub 2022 Sep 13. Lancet Rheumatol. 2022. PMID: 36118532 Free PMC article.
29 results